Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03321461 | TMTP1-ICG Mapping in Colposcopy-directed Biopsy | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT03870113 | DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2 | unknown | Phase 1 | 80 | Shenzhen People's HospitalOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine |
| unknown |
| Phase 1 |
| 15 |
| HealthBanks Biotech Co., Ltd.INDUSTRY |
| 0 |
| Jun 19, 2013 |
| clinicaltrials |
| NCT00493545 | Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia | unknown | Phase 1 | 24 | Nventa Biopharmaceuticals CorporationINDUSTRY | 1 | May 7, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jun 30, 2021source: clinicaltrials